Circulating microRNAs as potential biomarkers in cutaneous and mucosal leishmaniasis

Tegumentary leishmaniasis (TL) caused by protozoan of the genus Leishmania encompasses a spectrum of clinical manifestations, including cutaneous leishmaniasis (CL) and mucosal leishmaniasis (ML). Disease outcomes are strongly influenced by host immune responses, which are regulated in part by microRNAs (miRNAs). Circulating miRNAs are promising non-invasive biomarkers, but their value for distinguishing cutaneous and mucosal forms of leishmaniasis and for monitoring treatment response is poorly understood. We profiled circulating miRNAs in plasma from patients with CL, patients with ML and healthy controls using a PCR array of 84 inflammation- and autoimmunity-related miRNAs. Patients with CL were further stratified by therapeutic response, and paired plasma samples collected before and 90 days after treatment were analyzed. An exploratory in silico analysis was performed to identify predicted target genes and biological pathways of candidate miRNAs. Compared with healthy controls, patients with CL showed significant downregulation (P < 0.05) of miR-19b-3p, let-7b-5p, miR-16-5p, miR-424-5p, miR-19a-3p, miR-101-3p, miR-15a-5p, miR-9-5p and miR-144-3p, whereas let-7g-5p was significantly downregulated in ML. Direct comparison between ML and CL showed significant upregulation of miR-1324, miR-524-5p, miR-302b-3p, let-7b-5p and miR-520d-3p in ML. Before treatment, responders had higher levels of miR-1324, miR-34c-5p and miR-373-3p than non-responders, and longitudinal analyses revealed treatment-associated changes in miR-372-3p in responders and in let-7b-5p and miR-301b-3p in non-responders. In silico analyses linked candidate miRNAs to the adherens junction pathway. Circulating miRNA profiles therefore differ between the clinical forms investigated and according to therapeutic response, supporting their potential as non-invasive biomarkers for disease stratification and treatment monitoring.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-20
DOI
https://doi.org/10.21203/rs.3.rs-11695013/v1
Primary Topic
Research on Leishmaniasis Studies
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Circulating microRNAs as potential biomarkers in cutaneous and mucosal leishmaniasis

Hiro Goto, Eduardo Milton Ramos-Sanchez, Luiza Campos Reis, Pegine Walrad et al.
2 links
Research Square
Research on Leishmaniasis Studies
preprint

Circulating microRNAs as potential biomarkers in cutaneous and mucosal leishmaniasis

Hiro Goto, Eduardo Milton Ramos-Sanchez, Luiza Campos Reis, Pegine Walrad, Katerine G Madrid
preprint en

Abstract

Tegumentary leishmaniasis (TL) caused by protozoan of the genus Leishmania encompasses a spectrum of clinical manifestations, including cutaneous leishmaniasis (CL) and mucosal leishmaniasis (ML). Disease outcomes are strongly influenced by host immune responses, which are regulated in part by microRNAs (miRNAs). Circulating miRNAs are promising non-invasive biomarkers, but their value for distinguishing cutaneous and mucosal forms of leishmaniasis and for monitoring treatment response is poorly understood. We profiled circulating miRNAs in plasma from patients with CL, patients with ML and healthy controls using a PCR array of 84 inflammation- and autoimmunity-related miRNAs. Patients with CL were further stratified by therapeutic response, and paired plasma samples collected before and 90 days after treatment were analyzed. An exploratory in silico analysis was performed to identify predicted target genes and biological pathways of candidate miRNAs. Compared with healthy controls, patients with CL showed significant downregulation (P < 0.05) of miR-19b-3p, let-7b-5p, miR-16-5p, miR-424-5p, miR-19a-3p, miR-101-3p, miR-15a-5p, miR-9-5p and miR-144-3p, whereas let-7g-5p was significantly downregulated in ML. Direct comparison between ML and CL showed significant upregulation of miR-1324, miR-524-5p, miR-302b-3p, let-7b-5p and miR-520d-3p in ML. Before treatment, responders had higher levels of miR-1324, miR-34c-5p and miR-373-3p than non-responders, and longitudinal analyses revealed treatment-associated changes in miR-372-3p in responders and in let-7b-5p and miR-301b-3p in non-responders. In silico analyses linked candidate miRNAs to the adherens junction pathway. Circulating miRNA profiles therefore differ between the clinical forms investigated and according to therapeutic response, supporting their potential as non-invasive biomarkers for disease stratification and treatment monitoring.

Research Square
Universidade de São Paulo (BR), National University Toribio Rodríguez de Mendoza (PE), University of York (GB)
UK Research and Innovation, Fundação de Amparo à Pesquisa do Estado de São Paulo, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Medical Research Council
Good health and well-being
Research on Leishmaniasis Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon